Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.18 - $0.48 $2,051 - $5,471
-11,398 Reduced 56.21%
8,879 $2,000
Q1 2023

May 12, 2023

SELL
$0.34 - $1.19 $19,193 - $67,175
-56,450 Reduced 73.57%
20,277 $8,000
Q4 2022

Feb 10, 2023

BUY
$1.03 - $2.0 $70,214 - $136,338
68,169 Added 796.55%
76,727 $90,000
Q3 2022

Nov 14, 2022

BUY
$0.42 - $3.92 $793 - $7,404
1,889 Added 28.33%
8,558 $19,000
Q2 2022

Aug 12, 2022

SELL
N/A
-30,015 Reduced 81.82%
6,669 $0
Q1 2022

May 16, 2022

BUY
N/A
36,684 New
36,684 $353,000

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0

About GreenLight Biosciences Holdings, PBC


  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.